As a joint venture of Quest Diagnostics, Diagnostic Laboratory of Oklahoma (DLO) can provide testing for coronavirus (COVID-19) through Quest. Patients should be prioritized for testing of COVID-19 if they meet the CDC criteria, including those who may have been exposed to the virus or had contact with someone confirmed to have COVID-19, who show signs and symptoms (e.g., fever, cough, difficulty breathing), or who live in or recently traveled to a place where transmission of COVID-19 is prevalent. Due to the high demand nationwide for this test, you might experience a delay in turnaround times for results. Please be aware that specimens tested by DLO must be collected by a doctor or nurse in a clinical setting as DLO will not be collecting specimens at our patient service centers, contracted draw sites, or by our in-office phlebotomists. For more information on the new testing service, please read the following press release from Quest Diagnostics.

SECAUCUS, N.J., March 5, 2020 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced it will launch a coronavirus (COVID-19) test service. The new test service aids the presumptive detection of nucleic acid in respiratory specimens of patients meeting CDC's clinical criteria for COVID-19 testing.

Quest will be in position to receive specimens for testing, and begin to provide testing on Monday, March 9, 2020. With the new service, Quest Diagnostics will provide access to a COVID-19 test service for patients in the United States.

The new test service will be provided as a laboratory developed test, pending review by the FDA under emergency use authorization (EUA) which the company will submit per FDA guidance within 15 days of clinical testing. The test is a molecular based assay which detects viral RNA in respiratory specimens.

"In times of national health crises, quality laboratory testing is absolutely critical to mobilizing effective public health response," said Steve Rusckowski Chairman, CEO and President, Quest Diagnostics. "Quest's national scale, diagnostic expertise and innovation, and relationships with half the country's physicians and health systems is a vital complement to the efforts of the CDC and other public health labs to contend with a growing number of suspected COVID-19 cases in the United States. We applaud the FDA for providing the flexibility for innovative, quality lab developed tests to be brought to patients and providers quickly to advance effective response to the coronavirus outbreak."

The new service is expected to employ respiratory specimens collected in appropriate health care settings, such as hospitals and physician offices. Quest Diagnostics patient service centers and phlebotomy sites do not collect respiratory specimens on suspected COVID-19 cases. Patients suspected of, or confirmed to have, COVID-19 should consult with a physician regarding the best way to provide a specimen for testing by Quest.

Coronavirus Disease 2019 or COVID-19 (formally known as 2019-nCoV) is the name for the respiratory syndrome caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

Quest Diagnostics is a leader in infectious disease testing services, with a broad menu of molecular, antibody, and other test services to aid diagnosis, treatment and monitoring.

For more information about the company's response to COVID-19, visit www.questdiagnostics.com/home/Coronavirus/

About Quest Diagnostics
Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest Diagnostics annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our 47,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives.




Diagnostic Laboratory of Oklahoma (DLO), as a joint venture of Quest Diagnostics, is pleased to let you know that the following UnitedHealthcare Newsroom announcement was published on April 22, 2019.

UnitedHealthcare’s Triple Aim Focus Adding More Value for Lab Services

April 22, 2019

DLO named Preferred Lab Network Provider by UnitedHealthcareMore affordable procedure costs, shorter wait times, higher quality – everyone wants these things from their health care experience. UnitedHealthcare’s Triple Aim focus – improving health care affordability, outcomes and the patient experience – is now adding more value for lab services.

Consider this. Laboratory services are often the starting point to any medical procedure. During a doctor’s visit, a physician will recommend lab work about 50 percent of the time. These tests might include blood work like a complete blood count (CBC) or a thyroid panel. It may also include biopsy results or a genetic test which also happen in a lab. When a physician orders these tests, labs are often chosen based on habit or historical practice and the physician may not realize there could be a more affordable, higher quality option to offer to their patients.

UnitedHealthcare is working to make it easier to identify and choose lab providers who have committed to the Triple Aim within its broad network of more than 300 labs nationwide. Through the newly established Preferred Laboratory Network (PLN), physicians and their patients are likely to receive better health care value through improved access, quality and service at a lower cost. The creation of the PLN is an advanced way to work with selected lab providers to deliver care that places a greater emphasis on patient outcomes and the total cost of a person’s care.

Launching on July 1, 2019, UnitedHealthcare has selected the following labs to participate in its PLN: AmeriPath/DermPath, BioReference, GeneDx, Invitae, LabCorp, Mayo Clinic Laboratories and Quest Diagnostics. These labs were selected based on a rigorous quality review process.

How it impacts UnitedHealthcare consumers:

There is no change in lab access for consumers – consumers can still use a lab that is not in the PLN. However, choosing a lab in the PLN may lead to shorter wait times for services, online scheduling for patient service centers, higher quality of care and lower cost.

Services accessed through the PLN are at a lower average cost than other lab providers. For example, pathology services for a biopsy in the PLN would cost about $90. Consumers could still choose a lab not in the PLN, but the cost would increase to about $150. An out-of-network lab would cost more.

How it impacts physicians:

We expect physicians who refer to labs in the PLN to notice prompt turn-around times for lab results, ease-of-use when ordering labs electronically as well as easy access to physician-to-lab medical director consultations to support patient care. They will not need to do anything different to access services from these providers. Those participating in the PLN will be designated in UnitedHealthcare’s provider directories.

All of the participants in the PLN will be measured quarterly on their performance to ensure our doctors and patients receive the best care at the lowest cost.

Visit https://newsroom.uhc.com/experience/preferred-lab-network.html to view this release on the UnitedHealthcare website.


DLO acquires Cleveland HeartLab business in OklahomaDiagnostic Laboratory of Oklahoma (DLO) has announced that it has completed its acquisition of Cleveland HeartLab business in Oklahoma. As a joint venture of Quest Diagnostics and INTEGRIS Health, DLO will take part in Quest's first national center of excellence focused on heart disease diagnostics within Cleveland HeartLab's existing clinical laboratory facility in Cleveland.

The acquisition combines the expertise of Cleveland HeartLab's personalized evaluation of heart disease risk based on inflammation and other markers with Quest's Cardio IQ® lipid particle analysis and genetic and metabolic testing leadership. Heart disease is the number one cause of death in the United States. Conventional laboratory tests to assess cardiovascular disease, such as cholesterol panels, may not identify risk in all patients. New inflammation, genetic and other biomarkers may help physicians identify at-risk patients and guide treatment protocols to improve outcomes.

"Heart disease is the leading cause of death in Oklahoma," said DLO CEO Dennis Hogle. "By partnering with Cleveland HeartLab, DLO now offers innovative cardiometabolic diagnostic testing to the citizens of Oklahoma that can help identify potential risks, allowing for early intervention and treatment to achieve the best possible health outcomes."

In connection with the acquisition, Quest Diagnostics and Cleveland Clinic have also finalized a strategic collaboration intended to speed the commercialization of emerging innovations at Cleveland Clinic, including its Lerner Research Institute. The two entities also intend to collaborate on trials to demonstrate the clinical and economic value of these and other biomarkers. For 24 years in a row, the Cleveland Clinic has been ranked the best hospital in the country for cardiology and heart surgery by the U.S. News & World Report.


DLO named Best Places to Work in Oklahoma for 13 straight yearsDiagnostic Laboratory of Oklahoma (DLO) has been ranked as the No. 5 large company in the 2018 Best Places to Work in Oklahoma program, up one spot from 2017. DLO has been selected to the Best Places to Work in Oklahoma list for 13 straight years.

Each year, the Journal Record, the state’s oldest business publication, identifies and honors 40 companies as Oklahoma’s best employers. Of the 40 companies, 17 businesses were in the large category with 250 or more employees, while 23 companies were in the small/medium category. The final rankings were revealed on November 1 at the National Cowboy & Western Heritage Museum in Oklahoma City.

“The employees of DLO take pride is serving the citizens of Oklahoma, and this recognition only reinforces that commitment to the work we do," said Dennis Hogle, DLO’s Chief Executive Officer. "DLO plays a vital role in providing innovative, timely and quality medical laboratory services to help our clients make the proper medical decisions. It is truly an honor for DLO to be recognized for 13 years in a row and look forward to continuing to serve as Oklahoma's trusted laboratory partner."

The Journal Record teamed up with Best Companies Group to honor Oklahoma business and organizations excelling in creating quality workplaces. Companies are selected based on employee interviews and a look at their workplace policies, practices and demographics. Categories studied include: Leadership and Planning, Corporate Culture and Communications, Role Satisfaction, Work Environment and Relationship with Supervisor.

Below are the final rankings for both categories.

Large category (250 or more U.S. employees)

  1. Edward Jones
  2. Eide Bailly LLP
  3. Burns & McDonnell
  4. Heartland Payment Systems
  5. Diagnostic Laboratory of Oklahoma
  6. 180 Medical
  7. JE Dunn Construction
  8. Insurica
  9. Gallagher
  10. Capital One Auto Finance
  11. First United Bank
  12. CoreLogic
  13. CompSource Mutual Insurance Co.
  14. Alert 360 by Guardian Security Systems
  15. First Fidelity Bank
  16. Webco Industries
  17. Arvest Bank

Small/medium category (25-249 U.S. employees)

  1. Foundation Medical Staffing
  2. Wymer Brownlee Wealth Strategies
  3. Delta Dental of Oklahoma
  4. TBS Factoring Service
  5. Price Edwards & Company LLC
  6. Regent Bank
  7. Nextep Inc.
  8. Oseberg
  9. SafetySkills
  10. Northwest Technology Center
  11. Allegiance Credit Union
  12. Koch Communications
  13. Industrial Controls of Oklahoma
  14. InterWorks
  15. Daybreak Family Services
  16. Polston Tax Resolution and Accounting
  17. Cory’s Audio Visual
  18. Vox Printing
  19. Sunbeam Family Services
  20. BIS
  21. Republic Bank & Trust
  22. Oklahoma City Indian Clinic
  23. Public Strategies

DLO named to Best Places to Work in Oklahoma listThe Journal Record will recognize 40 Oklahoma companies at the 2018 Best Places to Work in Oklahoma program, which identifies and honors the state’s best employers, on Nov. 1 at the National Cowboy & Western Heritage Museum in Oklahoma City. This is the 13th consecutive year Diagnostic Laboratory of Oklahoma (DLO) has been selected as a finalist for this annual award.

“As an Oklahoma-based company, this recognition is extremely important to the employees of DLO," said Dennis Hogle, DLO’s Chief Executive Officer. "Our staff understands the importance of our role in providing innovative, timely and quality medical laboratory services to assist healthcare providers in making critical clinical decisions for our fellow Oklahomans. Our culture of service and quality is seen throughout our organization, and I am extremely proud of our employees and the dedication they have to DLO in order for us to be recognized for 13 years in a row."

The Journal Record teamed up with Best Companies Group to honor Oklahoma business and organizations excelling in creating quality workplaces. Companies are selected based on employee interviews and a look at their workplace policies, practices and demographics. Final ranking positions will be announced at the awards event. All 40 companies will receive the results of their surveys, which reveal their workplace strengths and weaknesses. Categories studied include: Leadership and Planning, Corporate Culture and Communications, Role Satisfaction, Work Environment and Relationship with Supervisor.

“The event is just the cherry on top," said Journal Record events manager Brittany Attaway. "Best Companies Group does all the legwork prior to the event to independently produce a report that provides a wealth of knowledge into each participating organization. The companies can put these findings into practice immediately for the betterment of the organization."

Nominees are divided into two categories – small/medium companies who employ between 25 and 249 U.S. employees and large companies that employ 250 or more people in the United States.

Large category (250 or more U.S. employees)
- 180 Medical
- Alert 360 by Guardian Security Systems (formerly Guardian Security Systems Inc.)
- Arvest Bank<
- Burns & McDonnell
- Capital One Auto Finance
- CompSource Mutual Insurance Co.
- CoreLogic
- Diagnostic Laboratory of Oklahoma
- Edward Jones
- Eide Bailly LLP
- First Fidelity Bank
- First United Bank
- Gallagher
- Heartland Payment Systems
- Insurica
- JE Dunn Construction
- Webco Industries

Small/medium category (25-249 U.S. employees)
- Allegiance Credit Union
- Cory’s Audio Visual
- Daybreak Family Services
- Delta Dental of Oklahoma
- Foundation Medical Staffing
- Industrial Controls of Oklahoma
- InterWorks
- Koch Communications
- Nextep Inc.
- Northwest Technology Center
- Oklahoma City Indian Clinic
- Oseberg
- Polston Tax Resolution and Accounting
- Price Edwards & Company LLC
- Public Strategies
- Regent Bank
- Republic Bank & Trust
- SafetySkills
- Sunbeam Family Services
- TBS Factoring Service
- Vox Printing
- Wymer Brownlee Wealth Strategies